Global Tumor Treatment Drug Market Size, Status and Forecast 2023-2027

Report ID: 888094 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tumor Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy (Biologic Therapy)
        1.2.5 Hormonal Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Tumor Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
    2.1 Global Tumor Treatment Drug Market Perspective (2016-2027)
    2.2 Tumor Treatment Drug Growth Trends by Regions
        2.2.1 Tumor Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Tumor Treatment Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Tumor Treatment Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Tumor Treatment Drug Industry Dynamic
        2.3.1 Tumor Treatment Drug Market Trends
        2.3.2 Tumor Treatment Drug Market Drivers
        2.3.3 Tumor Treatment Drug Market Challenges
        2.3.4 Tumor Treatment Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Tumor Treatment Drug Players by Revenue
        3.1.1 Global Top Tumor Treatment Drug Players by Revenue (2016-2021)
        3.1.2 Global Tumor Treatment Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Tumor Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Tumor Treatment Drug Revenue
    3.4 Global Tumor Treatment Drug Market Concentration Ratio
        3.4.1 Global Tumor Treatment Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tumor Treatment Drug Revenue in 2020
    3.5 Tumor Treatment Drug Key Players Head office and Area Served
    3.6 Key Players Tumor Treatment Drug Product Solution and Service
    3.7 Date of Enter into Tumor Treatment Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Treatment Drug Breakdown Data by Type
    4.1 Global Tumor Treatment Drug Historic Market Size by Type (2016-2021)
    4.2 Global Tumor Treatment Drug Forecasted Market Size by Type (2022-2027)

5 Tumor Treatment Drug Breakdown Data by Application
    5.1 Global Tumor Treatment Drug Historic Market Size by Application (2016-2021)
    5.2 Global Tumor Treatment Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Tumor Treatment Drug Market Size (2016-2027)
    6.2 North America Tumor Treatment Drug Market Size by Type
        6.2.1 North America Tumor Treatment Drug Market Size by Type (2016-2021)
        6.2.2 North America Tumor Treatment Drug Market Size by Type (2022-2027)
        6.2.3 North America Tumor Treatment Drug Market Size by Type (2016-2027)
    6.3 North America Tumor Treatment Drug Market Size by Application
        6.3.1 North America Tumor Treatment Drug Market Size by Application (2016-2021)
        6.3.2 North America Tumor Treatment Drug Market Size by Application (2022-2027)
        6.3.3 North America Tumor Treatment Drug Market Size by Application (2016-2027)
    6.4 North America Tumor Treatment Drug Market Size by Country
        6.4.1 North America Tumor Treatment Drug Market Size by Country (2016-2021)
        6.4.2 North America Tumor Treatment Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Tumor Treatment Drug Market Size (2016-2027)
    7.2 Europe Tumor Treatment Drug Market Size by Type
        7.2.1 Europe Tumor Treatment Drug Market Size by Type (2016-2021)
        7.2.2 Europe Tumor Treatment Drug Market Size by Type (2022-2027)
        7.2.3 Europe Tumor Treatment Drug Market Size by Type (2016-2027)
    7.3 Europe Tumor Treatment Drug Market Size by Application
        7.3.1 Europe Tumor Treatment Drug Market Size by Application (2016-2021)
        7.3.2 Europe Tumor Treatment Drug Market Size by Application (2022-2027)
        7.3.3 Europe Tumor Treatment Drug Market Size by Application (2016-2027)
    7.4 Europe Tumor Treatment Drug Market Size by Country
        7.4.1 Europe Tumor Treatment Drug Market Size by Country (2016-2021)
        7.4.2 Europe Tumor Treatment Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Tumor Treatment Drug Market Size (2016-2027)
    8.2 Asia-Pacific Tumor Treatment Drug Market Size by Type
        8.2.1 Asia-Pacific Tumor Treatment Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Tumor Treatment Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Tumor Treatment Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Tumor Treatment Drug Market Size by Application
        8.3.1 Asia-Pacific Tumor Treatment Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Tumor Treatment Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Tumor Treatment Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Tumor Treatment Drug Market Size by Region
        8.4.1 Asia-Pacific Tumor Treatment Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Tumor Treatment Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Tumor Treatment Drug Market Size (2016-2027)
    9.2 Latin America Tumor Treatment Drug Market Size by Type
        9.2.1 Latin America Tumor Treatment Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Tumor Treatment Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Tumor Treatment Drug Market Size by Type (2016-2027)
    9.3 Latin America Tumor Treatment Drug Market Size by Application
        9.3.1 Latin America Tumor Treatment Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Tumor Treatment Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Tumor Treatment Drug Market Size by Application (2016-2027)
    9.4 Latin America Tumor Treatment Drug Market Size by Country
        9.4.1 Latin America Tumor Treatment Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Tumor Treatment Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Tumor Treatment Drug Market Size (2016-2027)
    10.2 Middle East & Africa Tumor Treatment Drug Market Size by Type
        10.2.1 Middle East & Africa Tumor Treatment Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Tumor Treatment Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Tumor Treatment Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Tumor Treatment Drug Market Size by Application
        10.3.1 Middle East & Africa Tumor Treatment Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Tumor Treatment Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Tumor Treatment Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Tumor Treatment Drug Market Size by Country
        10.4.1 Middle East & Africa Tumor Treatment Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Tumor Treatment Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Tumor Treatment Drug Introduction
        11.1.4 Roche Revenue in Tumor Treatment Drug Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Celgene
        11.2.1 Celgene Company Details
        11.2.2 Celgene Business Overview
        11.2.3 Celgene Tumor Treatment Drug Introduction
        11.2.4 Celgene Revenue in Tumor Treatment Drug Business (2016-2021)
        11.2.5 Celgene Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Tumor Treatment Drug Introduction
        11.3.4 Novartis Revenue in Tumor Treatment Drug Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Tumor Treatment Drug Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2016-2021)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Tumor Treatment Drug Introduction
        11.5.4 Johnson & Johnson Revenue in Tumor Treatment Drug Business (2016-2021)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Merck & Co.
        11.6.1 Merck & Co. Company Details
        11.6.2 Merck & Co. Business Overview
        11.6.3 Merck & Co. Tumor Treatment Drug Introduction
        11.6.4 Merck & Co. Revenue in Tumor Treatment Drug Business (2016-2021)
        11.6.5 Merck & Co. Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Details
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Tumor Treatment Drug Introduction
        11.7.4 AstraZeneca Revenue in Tumor Treatment Drug Business (2016-2021)
        11.7.5 AstraZeneca Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Tumor Treatment Drug Introduction
        11.8.4 Pfizer Revenue in Tumor Treatment Drug Business (2016-2021)
        11.8.5 Pfizer Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Tumor Treatment Drug Introduction
        11.9.4 Amgen Revenue in Tumor Treatment Drug Business (2016-2021)
        11.9.5 Amgen Recent Development
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Details
        11.10.2 Eli Lilly Business Overview
        11.10.3 Eli Lilly Tumor Treatment Drug Introduction
        11.10.4 Eli Lilly Revenue in Tumor Treatment Drug Business (2016-2021)
        11.10.5 Eli Lilly Recent Development
    11.11 AbbVie
        11.11.1 AbbVie Company Details
        11.11.2 AbbVie Business Overview
        11.11.3 AbbVie Tumor Treatment Drug Introduction
        11.11.4 AbbVie Revenue in Tumor Treatment Drug Business (2016-2021)
        11.11.5 AbbVie Recent Development
    11.12 Takeda
        11.12.1 Takeda Company Details
        11.12.2 Takeda Business Overview
        11.12.3 Takeda Tumor Treatment Drug Introduction
        11.12.4 Takeda Revenue in Tumor Treatment Drug Business (2016-2021)
        11.12.5 Takeda Recent Development
    11.13 Astellas
        11.13.1 Astellas Company Details
        11.13.2 Astellas Business Overview
        11.13.3 Astellas Tumor Treatment Drug Introduction
        11.13.4 Astellas Revenue in Tumor Treatment Drug Business (2016-2021)
        11.13.5 Astellas Recent Development
    11.14 Ipsen
        11.14.1 Ipsen Company Details
        11.14.2 Ipsen Business Overview
        11.14.3 Ipsen Tumor Treatment Drug Introduction
        11.14.4 Ipsen Revenue in Tumor Treatment Drug Business (2016-2021)
        11.14.5 Ipsen Recent Development
    11.15 Sanofi
        11.15.1 Sanofi Company Details
        11.15.2 Sanofi Business Overview
        11.15.3 Sanofi Tumor Treatment Drug Introduction
        11.15.4 Sanofi Revenue in Tumor Treatment Drug Business (2016-2021)
        11.15.5 Sanofi Recent Development
    11.16 Bayer
        11.16.1 Bayer Company Details
        11.16.2 Bayer Business Overview
        11.16.3 Bayer Tumor Treatment Drug Introduction
        11.16.4 Bayer Revenue in Tumor Treatment Drug Business (2016-2021)
        11.16.5 Bayer Recent Development
    11.17 Biogen Idec
        11.17.1 Biogen Idec Company Details
        11.17.2 Biogen Idec Business Overview
        11.17.3 Biogen Idec Tumor Treatment Drug Introduction
        11.17.4 Biogen Idec Revenue in Tumor Treatment Drug Business (2016-2021)
        11.17.5 Biogen Idec Recent Development
    11.18 Teva
        11.18.1 Teva Company Details
        11.18.2 Teva Business Overview
        11.18.3 Teva Tumor Treatment Drug Introduction
        11.18.4 Teva Revenue in Tumor Treatment Drug Business (2016-2021)
        11.18.5 Teva Recent Development
    11.18 Otsuka
        .1 Otsuka Company Details
        .2 Otsuka Business Overview
        .3 Otsuka Tumor Treatment Drug Introduction
        .4 Otsuka Revenue in Tumor Treatment Drug Business (2016-2021)
        .5 Otsuka Recent Development
    11.20 Eisai
        11.20.1 Eisai Company Details
        11.20.2 Eisai Business Overview
        11.20.3 Eisai Tumor Treatment Drug Introduction
        11.20.4 Eisai Revenue in Tumor Treatment Drug Business (2016-2021)
        11.20.5 Eisai Recent Development
    11.21 Merck KGaA
        11.21.1 Merck KGaA Company Details
        11.21.2 Merck KGaA Business Overview
        11.21.3 Merck KGaA Tumor Treatment Drug Introduction
        11.21.4 Merck KGaA Revenue in Tumor Treatment Drug Business (2016-2021)
        11.21.5 Merck KGaA Recent Development
    11.22 Gilead Sciences
        11.22.1 Gilead Sciences Company Details
        11.22.2 Gilead Sciences Business Overview
        11.22.3 Gilead Sciences Tumor Treatment Drug Introduction
        11.22.4 Gilead Sciences Revenue in Tumor Treatment Drug Business (2016-2021)
        11.22.5 Gilead Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Tumor Treatment Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Immunotherapy (Biologic Therapy)
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Others
    Table 7. Global Tumor Treatment Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Tumor Treatment Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Tumor Treatment Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Tumor Treatment Drug Market Share by Regions (2016-2021)
    Table 11. Global Tumor Treatment Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Tumor Treatment Drug Market Share by Regions (2022-2027)
    Table 13. Tumor Treatment Drug Market Trends
    Table 14. Tumor Treatment Drug Market Drivers
    Table 15. Tumor Treatment Drug Market Challenges
    Table 16. Tumor Treatment Drug Market Restraints
    Table 17. Global Tumor Treatment Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Tumor Treatment Drug Market Share by Players (2016-2021)
    Table 19. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Treatment Drug as of 2020)
    Table 20. Ranking of Global Top Tumor Treatment Drug Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Tumor Treatment Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Tumor Treatment Drug Product Solution and Service
    Table 24. Date of Enter into Tumor Treatment Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Tumor Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Tumor Treatment Drug Revenue Market Share by Type (2016-2021)
    Table 28. Global Tumor Treatment Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Tumor Treatment Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Tumor Treatment Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Tumor Treatment Drug Revenue Market Share by Application (2016-2021)
    Table 32. Global Tumor Treatment Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Tumor Treatment Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Tumor Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Tumor Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Tumor Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Tumor Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Tumor Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Tumor Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Tumor Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Tumor Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Tumor Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Tumor Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Tumor Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Tumor Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Tumor Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Tumor Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Tumor Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Tumor Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Tumor Treatment Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Tumor Treatment Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Tumor Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Tumor Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Tumor Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Tumor Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Tumor Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Tumor Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Tumor Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Tumor Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Tumor Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Tumor Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Tumor Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Tumor Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Tumor Treatment Drug Product
    Table 67. Roche Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 68. Roche Recent Development
    Table 69. Celgene Company Details
    Table 70. Celgene Business Overview
    Table 71. Celgene Tumor Treatment Drug Product
    Table 72. Celgene Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 73. Celgene Recent Development
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Tumor Treatment Drug Product
    Table 77. Novartis Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 78. Novartis Recent Development
    Table 79. Bristol-Myers Squibb Company Details
    Table 80. Bristol-Myers Squibb Business Overview
    Table 81. Bristol-Myers Squibb Tumor Treatment Drug Product
    Table 82. Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 83. Bristol-Myers Squibb Recent Development
    Table 84. Johnson & Johnson Company Details
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Tumor Treatment Drug Product
    Table 87. Johnson & Johnson Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 88. Johnson & Johnson Recent Development
    Table 89. Merck & Co. Company Details
    Table 90. Merck & Co. Business Overview
    Table 91. Merck & Co. Tumor Treatment Drug Product
    Table 92. Merck & Co. Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 93. Merck & Co. Recent Development
    Table 94. AstraZeneca Company Details
    Table 95. AstraZeneca Business Overview
    Table 96. AstraZeneca Tumor Treatment Drug Product
    Table 97. AstraZeneca Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 98. AstraZeneca Recent Development
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 102. Pfizer Recent Development
    Table 103. Amgen Company Details
    Table 104. Amgen Business Overview
    Table 105. Amgen Tumor Treatment Drug Product
    Table 106. Amgen Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 107. Amgen Recent Development
    Table 108. Eli Lilly Company Details
    Table 109. Eli Lilly Business Overview
    Table 110. Eli Lilly Tumor Treatment Drug Product
    Table 111. Eli Lilly Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 112. Eli Lilly Recent Development
    Table 113. AbbVie Company Details
    Table 114. AbbVie Business Overview
    Table 115. AbbVie Tumor Treatment Drug Product
    Table 116. AbbVie Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 117. AbbVie Recent Development
    Table 118. Takeda Company Details
    Table 119. Takeda Business Overview
    Table 120. Takeda Tumor Treatment Drug Product
    Table 121. Takeda Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 122. Takeda Recent Development
    Table 123. Astellas Company Details
    Table 124. Astellas Business Overview
    Table 125. Astellas Tumor Treatment Drug Product
    Table 126. Astellas Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 127. Astellas Recent Development
    Table 128. Ipsen Company Details
    Table 129. Ipsen Business Overview
    Table 130. Ipsen Tumor Treatment Drug Product
    Table 131. Ipsen Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 132. Ipsen Recent Development
    Table 133. Sanofi Company Details
    Table 134. Sanofi Business Overview
    Table 135. Sanofi Tumor Treatment Drug Product
    Table 136. Sanofi Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 137. Sanofi Recent Development
    Table 138. Bayer Company Details
    Table 139. Bayer Business Overview
    Table 140. Bayer Tumor Treatment Drug Product
    Table 141. Bayer Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 142. Bayer Recent Development
    Table 143. Biogen Idec Company Details
    Table 144. Biogen Idec Business Overview
    Table 145. Biogen Idec Tumor Treatment Drug Product
    Table 146. Biogen Idec Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 147. Biogen Idec Recent Development
    Table 148. Teva Company Details
    Table 149. Teva Business Overview
    Table 150. Teva Tumor Treatment Drug Product
    Table 151. Teva Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 152. Teva Recent Development
    Table 153. Otsuka Company Details
    Table 154. Otsuka Business Overview
    Table 155. Otsuka Tumor Treatment Drug Product
    Table 156. Otsuka Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 157. Otsuka Recent Development
    Table 158. Eisai Company Details
    Table 159. Eisai Business Overview
    Table 160. Eisai Tumor Treatment Drug Product
    Table 161. Eisai Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 162. Eisai Recent Development
    Table 163. Merck KGaA Company Details
    Table 164. Merck KGaA Business Overview
    Table 165. Merck KGaA Tumor Treatment Drug Product
    Table 166. Merck KGaA Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 167. Merck KGaA Recent Development
    Table 168. Gilead Sciences Company Details
    Table 169. Gilead Sciences Business Overview
    Table 170. Gilead Sciences Tumor Treatment Drug Product
    Table 171. Gilead Sciences Revenue in Tumor Treatment Drug Business (2016-2021) & (US$ Million)
    Table 172. Gilead Sciences Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tumor Treatment Drug Market Share by Type: 2020 VS 2027
    Figure 2. Chemotherapy Features
    Figure 3. Targeted Therapy Features
    Figure 4. Immunotherapy (Biologic Therapy) Features
    Figure 5. Hormonal Therapy Features
    Figure 6. Others Features
    Figure 7. Global Tumor Treatment Drug Market Share by Application: 2020 VS 2027
    Figure 8. Blood Cancer Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Gastrointestinal Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Respiratory/Lung Cancer Case Studies
    Figure 13. Others Case Studies
    Figure 14. Tumor Treatment Drug Report Years Considered
    Figure 15. Global Tumor Treatment Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Tumor Treatment Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Tumor Treatment Drug Market Share by Regions: 2020 VS 2027
    Figure 18. Global Tumor Treatment Drug Market Share by Regions (2022-2027)
    Figure 19. Global Tumor Treatment Drug Market Share by Players in 2020
    Figure 20. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Treatment Drug as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Tumor Treatment Drug Revenue in 2020
    Figure 22. Global Tumor Treatment Drug Revenue Market Share by Type (2016-2021)
    Figure 23. Global Tumor Treatment Drug Revenue Market Share by Type (2022-2027)
    Figure 24. North America Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Tumor Treatment Drug Market Share by Type (2016-2027)
    Figure 26. North America Tumor Treatment Drug Market Share by Application (2016-2027)
    Figure 27. North America Tumor Treatment Drug Market Share by Country (2016-2027)
    Figure 28. United States Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Tumor Treatment Drug Market Share by Type (2016-2027)
    Figure 32. Europe Tumor Treatment Drug Market Share by Application (2016-2027)
    Figure 33. Europe Tumor Treatment Drug Market Share by Country (2016-2027)
    Figure 34. Germany Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Tumor Treatment Drug Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Tumor Treatment Drug Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Tumor Treatment Drug Market Share by Region (2016-2027)
    Figure 44. China Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Tumor Treatment Drug Market Share by Type (2016-2027)
    Figure 52. Latin America Tumor Treatment Drug Market Share by Application (2016-2027)
    Figure 53. Latin America Tumor Treatment Drug Market Share by Country (2016-2027)
    Figure 54. Mexico Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Tumor Treatment Drug Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Tumor Treatment Drug Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Tumor Treatment Drug Market Share by Country (2016-2027)
    Figure 60. Turkey Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Tumor Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Roche Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 68. Merck & Co. Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 69. AstraZeneca Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 71. Amgen Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 72. Eli Lilly Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 73. AbbVie Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 74. Takeda Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 75. Astellas Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 76. Ipsen Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 77. Sanofi Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 78. Bayer Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 79. Biogen Idec Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 80. Teva Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 81. Otsuka Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 82. Eisai Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 83. Merck KGaA Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 84. Gilead Sciences Revenue Growth Rate in Tumor Treatment Drug Business (2016-2021)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Frequently Asked Questions
Tumor Treatment Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tumor Treatment Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tumor Treatment Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports